Share “Oklahoma City biotech startup seeks...”

Oklahoma City biotech startup seeks funding for clinical trials

Oklahoma City’s EpimedX trying to develop treatment for sickle cell disease, which affects more than 90,000 people in the United States.

BY BRIANNA BAILEY Published: January 10, 2013
Advertisement

Local biotech startup EpimedX believes a drug known as Edx-17 could help treat annually more than 90,000 patients with sickle cell disease in the United States.

“Sickle cell disease...
Read the rest of the story on Oklahoman.com
NewsOK.com has disabled the comments for this article.

AROUND THE WEB

  1. 1
    Priceline.com reveals top Labor Day, Fall destinations for 2015
  2. 2
    Rep. Jim Bridenstine recognized for leadership on space issues
  3. 3
    Susan Sarandon calls upcoming Glossip execution 'a horrible thing' on 'Dr. Phil'
  4. 4
    Barricaded man who threatened Claremore police officers sentenced to 20 years in prison
  5. 5
    Cat takes a bullet and saves 3-year-old
+ show more

FEATURED JOBS



× Trending news Article